UBE2E2-AS1

Across TCGA pan-cancer cohorts, UBE2E2-AS1 RNA is linked to patient survival in 21 of 34 cancer types, making it the most broadly survival-associated UBE2E2-AS1 data layer.

The strongest signal is observed in bladder urothelial carcinoma (BLCA), where higher UBE2E2-AS1 RNA is associated with worse overall survival. In most high-consensus cancer types, elevated UBE2E2-AS1 expression acts as an unfavorable survival marker, although some lineages such as PAAD and ACC show a favorable association.

BLCA, LIHC, and READ are the cancer types where UBE2E2-AS1 RNA most reproducibly stratifies survival.

RNA survival associations by lineage

Ranked by sampling consensus. AUC1 and AUC2 indicate survival in the high- and low-expression groups, respectively; the lower AUC marks the poorer-surviving group. p-values are from the log-rank test.

Lineage	Measure	Split	Stage	AUC1 high	AUC2 low	p	Sampling consensus
BLCA	OS	Tertile	IV	0.257	0.686	<.001	34	view →
LIHC	OS	Quartile	II,III,IV	0.380	0.692	.007	34	view →
READ	OS	Tertile	III,IV	0.345	0.802	.007	30	view →
LUSC	DFS	Quartile	II,III,IV	0.256	0.436	.008	27	view →
LGG	OS	Quartile	All	0.336	0.537	<.001	16	view →
PAAD	OS	Median	All	0.443	0.269	.024	11	view →
ACC	OS	Tertile	III,IV	0.919	0.674	.035	11	view →
CHOL	DFS	Median	III,IV	0.133	0.779	.038	9	view →
THCA	DFS	Median	All	0.964	0.859	.010	9	view →
KIRP	DFS	Tertile	All	0.955	0.543	.017	8	view →
SARC	OS	Tertile	All	0.645	0.830	.014	8	view →
GBM	OS	Quartile	All	0.216	0.444	.012	6	view →

Pink = unfavorable, green = favorable. Showing the 12 strongest of 21 lineages.

UBE2E2-AS1–BLCA (OS)

Open the BLCA breakdown →